Florin Mitu | Cardiology | Research Excellence Award

Mr. Florin Mitu | Cardiology | Research Excellence Award

Mr. Florin Mitu | University of Medicine and Pharmacy | Romania

Mr. Florin Mitu is a distinguished university professor at the VIth Medical Clinic of “Gr. T. Popa” University of Medicine and Pharmacy, Iași, where he has served since 2014 as head of discipline, coordinator of teaching activities in medical semiology, and course holder for third-year general medicine as well as coordinator of optional courses in preventive cardiology and cardiovascular rehabilitation for years III–V. He supervises student groups, diploma theses, residency courses, and postgraduate programs, contributing extensively to medical education. Since 2014, he has been accredited to supervise doctoral theses, actively guiding research in medicine and supporting national academic development. In parallel, he is a specialist physician in physical medicine, rehabilitation, and balneophysiotherapy at the Clinical Rehabilitation Hospital, Cardiovascular Recovery Clinic in Iași, where he carries out intensive clinical activity. His leadership roles include tenure as Head of the VIth Medical Clinic and Head of the Cardiovascular Recovery Section, overseeing medical, administrative, and research activities. Between 2011 and 2014, he served as Director of the Medical Department I and member of the Faculty Council, contributing to academic governance, and between 2008–2010, 2016–2019, and 2020–2023, he was an active member of the University Senate. Previously, he was General Director of the Clinical Rehabilitation Hospital (2002–2004), managing its medical and administrative functions. His academic career spans decades, including roles as associate professor (2003–2014), lecturer (1999–2003), and teaching assistant (1991–1999), with continuous responsibilities in teaching semiology, supervising students, and instructing residents. His early international training included professional medical internships in cardiac rehabilitation in Switzerland (University of Berne) and Belgium (Centre Hospitalier Universitaire de Liège). He began his career as a general practitioner and medical intern in Iași county hospitals. His educational background includes a Master’s degree in Health Services Management from “Alexandru Ioan Cuza” University, focusing on organizational and financial management in healthcare. He has served as a member of habilitation and doctoral committees from 2014 to 2024 and continues to contribute to national specialty commissions in internal medicine and cardiology. His scientific contribution is substantial, with 170 published documents, 921 citations indexed across 858 citing documents, and an h-index of 14, reflecting his long-term impact in medical education, internal medicine, cardiovascular recovery, and clinical research. Through sustained academic, clinical, managerial, and research activity, he has established a leading role in Romanian medical science and mentorship.

Profiles: Scopus | Google Scholar

Featured Publications

Dorobantu, M., Tautu, O. F., Dimulescu, D., Sinescu, C., Gusbeth-Tatomir, P., et al. (2018). Perspectives on hypertension’s prevalence, treatment and control in a high cardiovascular risk East European country: Data from the SEPHAR III survey. Journal of Hypertension, 36(3), 690–700.

Dorobantu, M., Darabont, R., Ghiorghe, S., Arsenescu-Georgescu, C., et al. (2014). Hypertension prevalence and control in Romania at a seven-year interval: Comparison of SEPHAR I and II surveys. Journal of Hypertension, 32(1), 39–47.

Cojocariu, S. A., Maștaleru, A., Sascău, R. A., Stătescu, C., Mitu, F., et al. (2021). Neuropsychiatric consequences of lipophilic beta-blockers. Medicina, 57(2), 155.

Iurciuc, S., Cimpean, A. M., Mitu, F., Heredea, R., & Iurciuc, M. (2017). Vascular aging and subclinical atherosclerosis: Why such a “never ending” and challenging story in cardiology? Clinical Interventions in Aging, 1339–1345.

Marcu, D. T. M., Adam, C. A., Mitu, F., Cumpat, C., Aursulesei Onofrei, V., et al. (2023). Cardiovascular involvement in tuberculosis: From pathophysiology to diagnosis and complications A narrative review. Diagnostics, 13(3), 432.

Adam, C. A., Anghel, R., Marcu, D. T. M., Mitu, O., Roca, M., & Mitu, F. (2022). Impact of sodium–glucose cotransporter 2 (SGLT2) inhibitors on arterial stiffness and vascular aging What do we know so far? (A narrative review). Life, 12(6), 803.

Zbigniew Nowak | Cardiology and Physical Activity | Innovative Research Award

Prof. Zbigniew Nowak | Cardiology and Physical Activity | Innovative Research Award 

Prof. Zbigniew Nowak | Jerzy Kukuczka Academy of Physical Education Katowice | Poland

Prof. Zbigniew Nowak is a distinguished Professor at the Academy of Physical Education in Katowice and currently serves as the Head of the Department of Physiotherapy in Internal Medicine. With over 19 years of clinical experience in cardiac diagnosis and rehabilitation, he has worked extensively in departments of cardiology, cardiac surgery for both adults and children, electrophysiology, and intensive care. Prof. Nowak is the author of 132 scientific publications in Polish and international journals and 11 monographs, contributing significantly to the fields of cardiology, physiotherapy, and cardiac rehabilitation. His scholarly work has earned him an h-index of 14 and over 1,200 citations, reflecting his substantial influence in medical and rehabilitation sciences. He has actively participated in 44 national and international conferences and successfully implemented eight major scientific programs in cardiology. His ongoing research focuses on the prevention of cardiovascular diseases and the development of innovative cardiac rehabilitation programs that improve patient recovery and quality of life. As an academic mentor, Prof. Nowak has supervised 21 PhD dissertations and over 700 master’s and bachelor’s theses, fostering the next generation of medical professionals. His teaching expertise encompasses a broad range of subjects including coronary artery disease, myocardial infarction, congenital and acquired valvular diseases, hypertension, interventional cardiology, cardiac surgery, stress testing, and preventive cardiology. He is also an active member of the European Society of Cardiology, contributing to collaborative advancements in heart disease prevention and rehabilitation strategies. Prof. Nowak’s career exemplifies a balance of clinical excellence, educational leadership, and impactful scientific contribution in cardiovascular health.

Profile: Scopus | Orcid | Google Scholar 

Featured Publications

Gloc, D., Plewa, M., & Nowak, Z. (2012). The effects of kyokushin karate training on the anthropometry and body composition of advanced female and male practitioners. Journal of Combat Sports and Martial Arts, 3(2), 63–71.

Nowak, Z., Plewa, M., Skowron, M., Markiewicz, A., Kucio, C., & Osiadło, G. (2010). Paffenbarger Physical Activity Questionnaire as an additional tool in clinical assessment of patients with coronary artery disease treated with angioplasty. Polish Heart Journal (Kardiologia Polska), 68(1), 32–39.

Nowak, A., Morawiec, M., Gabrys, T., Nowak, Z., Szmatlan-Gabryś, U., … (2020). Effectiveness of resistance training with the use of a suspension system in patients after myocardial infarction. International Journal of Environmental Research and Public Health, 17(15), 5383.

Grabara, M., Nowak, Z., & Nowak, A. (2020). Effect of Hatha Yoga on cardiac hemodynamic parameters and physical capacity in cardiac rehabilitation patients. Journal of Cardiopulmonary Rehabilitation and Prevention, 40(4), 263–267.

Nowak, Z., Plewa, M., Skowron, M., Osiadlo, G., Markiewicz, A., & Kucio, C. (2010). Minnesota leisure time physical activity questionnaire as an additional tool in clinical assessment of patients undergoing percutaneous coronary interventions. Journal of Human Kinetics, 23, 79–87.

Milewski, K., Małecki, A., Orszulik-Baron, D., Kachel, M., Hirnle, P., Orczyk, M., … (2019). The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design. Cardiology Journal, 26(5), 594–603.

Carlos Escobar | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Carlos Escobar | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Carlos Escobar | Hospital La Paz, Madrid | Spain

Dr. Carlos Escobar Cervantes is a leading cardiologist and researcher based in Madrid, Spain. With over two decades of experience in cardiovascular medicine, he has held esteemed roles in top Spanish hospitals, contributed prolifically to scientific literature, and has played leadership roles within major cardiology societies. He currently serves as Facultativo Adjunto del Servicio de Cardiología at Hospital Universitario La Paz and is the Scientific Director of the Consorcio DTX, focusing on digital therapeutics (DTx) and AI in health. His work bridges clinical expertise and digital innovation, making him a pioneer in the integration of artificial intelligence in cardiovascular care. Dr. Escobar’s dedication extends beyond patient care—he is also a respected academic and educator, shaping future medical professionals. His contribution to cardiovascular pharmacology, hypertension, ischemic heart disease, and public health through clinical trials, publications, and professional society work makes him an exemplary candidate for international recognition.

Profile

Orcid

Education

Dr. Carlos Escobar Cervantes earned his Medical Degree in Medicine and Surgery from the Universidad Autónoma de Madrid (1993–1999). He pursued academic excellence and scientific inquiry further by completing a PhD in Medicine at the Universidad de Alcalá in 2007, where he was awarded the prestigious distinction of Sobresaliente Cum Laude, by unanimous decision of the examining board. This rigorous academic path provided him with a strong foundation for his career in internal medicine, clinical cardiology, and scientific research. Additionally, his commitment to academic growth is reflected in his successful qualification as a Profesor Ayudante Doctor recognized by ANECA in June 2011. Further enriching his academic and leadership portfolio, Dr. Escobar completed the Leadership Development Program in Public Healthcare Organizations from ESADE Business School (2011–2012), one of Spain’s most prestigious business institutions. His education uniquely combines clinical, scientific, and managerial expertise—vital for innovative cardiovascular leadership.

Professional Experience

Dr. Escobar Cervantes has held successive and prestigious roles in cardiology across some of Madrid’s foremost healthcare institutions. He began his career as a Médico Adjunto de Cardiología at Hospital Universitario Ramón y Cajal (2006–2008), then transitioned to Hospital Universitario Infanta Sofía (2008–2012), and has been serving at Hospital Universitario La Paz since 2012. Currently, he also coordinates outpatient cardiology services and care continuity at La Paz, a role he took on in June 2023, showcasing his capacity for healthcare system organization and innovation. Since December 2023, Dr. Escobar has been the Scientific Director of the Consorcio DTX, focused on the application of digital health tools, including AI, in cardiology. He is also the Co-founder of Samira DTX, emphasizing his proactive stance in developing evidence-based digital therapeutic solutions. His career represents a seamless integration of bedside excellence, scientific leadership, and organizational impact in Spanish and international cardiology.

Research Interests

Dr. Escobar’s research focuses on ischemic heart disease, arterial hypertension, atrial fibrillation, and pulmonary thromboembolism. As both principal investigator and co-investigator, he has played key roles in clinical trials exploring innovative therapies in these domains. In recent years, he has expanded his research to encompass digital therapeutics (DTx) and the application of artificial intelligence (AI) in cardiovascular medicine. He is an active contributor to the Sociedad Española de Cardiología (SEC) and the European Society of Cardiology, where he is a member of the cardiovascular pharmacology and hypertension working groups. His research is deeply translational—bringing bench-side developments to bedside application. His commitment to improving cardiovascular care outcomes through technological innovation, patient-centered care models, and robust clinical investigation underscores his status as a forward-thinking leader in cardiovascular science. Dr. Escobar’s dual commitment to both scientific discovery and clinical impact has made him a valued voice in the cardiology research community.

Awards and Professional Recognition

Dr. Carlos Escobar is a highly respected figure in cardiology, having served as President of the Clinical Cardiology Section of the Sociedad Española de Cardiología (SEC). He has been a member of the SEC’s Research Agency and is an active contributor to several working groups under both SEC and the European Society of Cardiology (ESC). His academic and research contributions have earned him memberships in international editorial boards such as the World Journal of Hypertension, ISRN Nephrology, and the Journal of Cardiology and Therapeutics. His peer-review activity includes esteemed journals like Annals of Internal Medicine, Diabetes Care, and the Journal of Hypertension, reflecting his reputation as an authority in cardiovascular science. These honors reflect a career distinguished not only by scientific productivity but also by community trust and professional excellence. His leadership, publications, and collaborative spirit make him a worthy nominee for high-level international awards.

Publications Top Notes

Cost-utility analysis of dapagliflozin for the treatment of symptomatic chronic heart failure in Spain

The gut microbiota and its role in the development of cardiovascular disease

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis

Artificial intelligence: a promising tool for the clinical cardiologist

Magnitude of chronic kidney disease in Spain

Conclusion

Dr. Carlos Escobar Cervantes exemplifies the union of clinical excellence, academic integrity, and technological foresight. His contributions to cardiology span groundbreaking clinical research, digital health innovation, and transformative educational leadership. His work has directly improved cardiovascular care standards in Spain and beyond, earning him recognition across editorial boards, societies, and digital medicine consortia. Dr. Escobar is not only a scientific leader but also an innovator, teacher, and strategist, positioning him as a well-rounded and future-focused candidate for any top-tier international medical or scientific award. His pioneering initiatives in AI-driven cardiovascular therapeutics, combined with his extensive academic publications and clinical leadership, embody the spirit of 21st-century medical excellence. He is therefore highly recommended for recognition in awards celebrating innovation, excellence, and translational impact in cardiovascular medicine.

Hua He | Cardiovascular diseases | Best Researcher Award

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University, China

Profile

Orcid

🎓 Early Academic Pursuits

Professor Hua He graduated from the prestigious Peking Union Medical College in 2006, earning a doctorate in internal medicine. This solid academic foundation laid the groundwork for his career in cardiovascular medicine and clinical research, with an early focus on coronary heart disease, arrhythmia, and heart failure.

💼 Professional Endeavors

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor He has dedicated himself to advancing clinical and basic research in cardiovascular diseases. His leadership includes managing several key projects related to ischemic heart disease and stem cell therapies, reflecting his commitment to bridging clinical practice and innovative research.

🔬 Contributions and Research Focus

Over recent years, Professor He has focused on the therapeutic potential of human umbilical cord mesenchymal stem cell exosomes in the treatment of ischemic heart disease. His pioneering work demonstrates how these exosomes improve ventricular remodeling and long-term cardiac function following myocardial infarction. He has also contributed to elucidating the molecular mechanisms and biological dynamics of stem cell-derived exosomes both in vivo and in vitro, publishing 17 articles in high-impact journals.

🌍 Impact and Influence

Through his role as senior editor of Clinical and Applied Thrombosis Hemostasis and reviewer for Stem Cell Research and Therapy, Professor He has influenced the direction of research in cardiovascular regenerative medicine. His expertise is further recognized by his involvement as a project reviewer for the National Natural Science Foundation of China and as a medical identification expert for several Beijing medical associations.

📊 Academic Citations

With 17 journal publications and a citation index of 7, Professor He’s research contributions are well acknowledged in the scientific community. His ongoing research projects (eight completed or in progress) and patent filings highlight a strong commitment to innovation and knowledge dissemination.

💻 Technical Skills

Professor He possesses advanced technical skills in stem cell biology, molecular analysis, and cardiovascular disease modeling. His proficiency in translational research techniques has enabled successful exploration of novel therapies for myocardial ischemia/reperfusion injury.

🎓 Teaching Experience

In addition to his research activities, Professor He contributes to medical education by mentoring young clinicians and researchers, fostering the next generation of cardiovascular specialists through practical and theoretical training.

🔮 Legacy and Future Contributions

Professor He’s research advances the frontier of regenerative cardiovascular medicine, particularly in stem cell-derived exosome therapy. His ongoing projects and expert collaborations promise significant breakthroughs that could transform treatment protocols for ischemic heart disease worldwide.

📚 Selected Publications

  • He, H., et al. "Human umbilical cord mesenchymal stem cell exosomes improve ventricular remodeling after myocardial infarction." Journal of Cardiovascular Research, 2021.

  • He, H., Wang, X., et al. "Therapeutic effects of mesenchymal stem cell exosomes on ischemia/reperfusion injury in rat models." Stem Cell Therapy, 2022.

  • He, H., Zhang, Y., et al. "Molecular mechanisms of exosome-mediated cardiac repair post-infarction." Cellular and Molecular Medicine, 2020.

  • He, H., Li, Q., et al. "In vivo biodistribution and pharmacodynamics of human umbilical cord MSC-derived exosomes." Frontiers in Cardiovascular Medicine, 2019.

  • He, H., Chen, J., et al. "Mesenchymal stem cell exosomes modulate inflammation and fibrosis in cardiac tissue." International Journal of Cardiology, 2021.

  • He, H., Liu, S., et al. "Safety assessment of MSC exosome therapy in myocardial ischemia/reperfusion." Stem Cells Translational Medicine, 2023.

  • He, H., et al. "Exosome-based delivery of therapeutic molecules for heart failure treatment." Theranostics, 2022.